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Objective: To investigate the effects and potential mechanisms of preconditioning of tricarbonyldichlororuthe-
nium (III) dimer (CORM-2)-liberated CO on LPS-induced activation of endothelial cells (HUVEC).   
Methods: HUVEC were pretreated with CORM-2 at the concentration of 50 or 100μM for 2 hrs, washed and 
stimulated with LPS (10μg/ml) for additional 4 hrs. Activation (oxidative stress) of HUVEC was assessed by 
measuring intracellular oxidation of DHR 123 or nitration of DAF-FM, specific H2O2 and NO fluorochromes, 
respectively. The expression of HO-1, iNOS (Western blot) and ICAM-1 (cell ELISA) proteins    and activation of 
inflammation-relevant transcription factor, NF-κB (EMSA) were assessed. In addition, PMN adhesion to 
HUVEC was also assessed.   
Results: The obtained data indicate that pretreatment of HUVEC with CORM-2 results in: 1) decrease of 
LPS-induced production of ROS and NO; 2) up-regulation of HO-1 but decrease in iNOS at the protein levels; 3) 
inhibition of LPS-induced activation of NF-κB; and 4) downregulation of expression of ICAM-1, and this was 
accompanied by a decrease of PMN adhesion to LPS-stimulated HUVEC. 
Conclusions: Preconditioning of CO liberated by CORM-2 elicited its anti-inflammatory effects by interfering 
with the induction of intracellular oxidative stress. In addition, it also supports the notion that CO is a potent 
inhibitor of iNOS and NF-κB. 
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Introduction 
Endothelial cells (ECs) control many aspects of 
haemostasis, immunity and inflammatory reactions in 
addition to its function as a selective barrier between 
the blood and the tissues. In the inflammation process, 
the activation of ECs is recognized as an early step 
that involves the expression of several adhesion 
molecules [1]. Also, one of the primary cellular targets 
of the inflammatory cytokines and their modulatory 
factors is the endothelial cell, whose activation is cru-
cial during inflammatory processes [2]. This activation 
triggers a change from a non-thrombogenic surface to 
one in which circulating cells adhere to the apical 
membrane of endothelial cells [3]. Increased expres-
sion of cell adhesion molecules such as ICAM-1, 
VCAM-1 and E-selectin are characteristic of the al-
tered gene expression pattern of the activated endo-
thelial cell [4,5]. This process in particular leads to 
thrombogenesis and extravasation of leukocytes into 
the tissues [6]. It has been shown that endothelial cell 
activation, at the molecular level, is characterized by 
the translocation of the transcription factor NF- κB 
into the nucleus and an immediate NF- κB-dependent 
gene activation [7,8]. 
Bacterial LPS is known to be an in vivo trigger for 
EC activation, and it has been shown to induce func-
tional alterations in ECs in in vitro culture, including 
the synthesis and release of IL-6 and IL-8 and altera-
tions in the expression of cell surface structures in-
volved in adhesion [9-11]. LPS is an integral compo-
nent of the outer membrane of all Gram-negative bac-
teria. It is released from their surface during both in 
vitro and in vivo growth or may originate from the 
lysis of the bacterial cell following exposure to antibi-
otics or human serum [12,13]. LPS can initiate a potent 
inflammatory response when large amounts enter 
c i r c u l a t i o n ,  s u c h  a s  d u r i n g  e n d o t o x e m i a  [ 1 4 ] .  I n  t h e  
present study, LPS was used to stimulate HUVECs, Int. J. Biol. Sci. 2008, 4 
 
271
which were then activated to mimic the inflammation 
process. 
Carbon monoxide (CO) has long been known in 
biology and medicine as a toxic compound, due to its 
ability to bind hemoglobin with a much higher affinity 
than oxygen [15]. Evidence accumulated to date sug-
gests that endogenous carbon monoxide (CO), a 
b i - p r o d u c t  o f  i n d u c i b l e  h e m e  o x y g e n a s e  ( H O - 1 )  c a n  
modulate inflammation, inhibits lipopolysaccharide 
(LPS)-induced production of cytokines both in vivo 
and in vitro, and consequently exhibits important cy-
toprotective function and anti-inflammatory proper-
ties that are beneficial for the resolution of acute in-
flammation [16-18]. Inhaled CO at concentrations of 
250–500 parts per million (ppm) has also been shown 
t o  b e  b e n e f i c i a l  i n  a  n u m b e r  o f  l u n g  i n j u r y  m o d e l s ,  
including hyperoxic injury  allergen-induced inflam-
mation [19]. 
Recently, transitional metal carbonyls have been 
identified as potential CO-releasing molecules 
(CO-RMs) with the potential to facilitate the pharma-
ceutical use of CO by delivering it to tissues and or-
gans [20]. CO-RMs have been shown to act pharma-
cologically in rat aortic and cardiac tissue where lib-
eration of CO produced vasorelaxant effects [21-24] 
and decreased myocardial ischemia – reperfusion 
damage [25,26] in the absence of dramatic changes in 
blood carboxy-hemoglobin (COHb) levels. 
On the basis of these data, the present study was, 
therefore, designed as a prospective laboratory ex-
periment to investigate the effects of preconditioning 
of tricarbonyldichlororuthenium (II) dimer (CORM-2) 
[27], one of the novel group of CO-RMs, on decrease 
of inflammatory responses  and oxidative stress in 
LPS-stimulated HUVECs (human umbilical vein en-
dothelial cells), and discussed the possible molecular 
mechanisms. Our results show that preconditioning of 
endothelial cells (HUVEC) by CO liberated from 
CORM-2 elicits anti-inflammatory effects by interfer-
ing with redox-sensitive cell signaling and subsequent 
inhibition of pro-adhesive phenotype. In addition, it 
also supports the notion that CO is a potent inhibitor 
of iNOS. 
Material and methods 
Materials  
Medium 199 (M199), fetal calf serum (FCS), peni-
cillin, and streptomycin were purchased from GIBCO 
BRL (Gland Island, NY). Tricarbonyldichlororuthe-
nium(II) dimer (CORM-2) was obtained from Sigma 
Aldrich and solubilized in dimethyl sulfoxide (DMSO) 
to obtain a 10mM stock. LPS (Escherichia coli serotype 
055:B5) was purchased from Sigma. Anti-ICAM-1, 
HO-1 and iNOS polyclonal antibodies were purchased 
from Transduction Laboratories (Lexington, KY). 
Anti-mouse IgG conjugated to horseradish peroxidase 
was purchased from Kirkegaard and Perry Laborato-
ries (Gaithersburg, MD).   
Isolation and culture of human umbilical vein endo-
thelial cells (HUVEC) 
Human umbilical vein endothelial cells (HUVEC) 
were harvested from the fresh human umbilical vein 
of newborns by collagenase treatment (Worthington 
Biochem, Freehold, NJ) as previously described 
[28,29]. The cells were grown in medium 199(M199; 
GIBCO, Burlington, Canada) supplemented with 10% 
heat-inactivated FCS (Intergen, Purchase, NY), 
2.4mg/l thymidine (Sigma Chemical, Oakville, Can-
ada), 10IU/ml heparin sodium, antibiotics (100U/ml 
penicillin and 100µg/ml streptomycin; GIBCO), 
1.5µg/ml fungizone (GIBCO), and 80µg/ml endothe-
lial mitogen (Biomedical chnologies, Stoughten, MA). 
The cell cultures were incubated in room air with 5% 
CO2 at 37°C and 95% humidity and were expanded by 
brief trypsinization with 0.25% trypsin in PBS con-
taining 0.025% EDTA. The experiments were con-
ducted on passage 3-5 HUVECs. After 18h, the me-
dium was changed to 500μl of fresh complete M199. 
Cells were pre-treated with CORM-2 (50 and 100μM) 
for 2h followed by stimulating with LPS (10μg/ml) for 
additional 4h. Cells co-incubated with CORM-2 (50 
and 100μM) were as the controls. After stimulation for 
4 h, the cells and medium were harvested separately. 
Oxidant production 
Oxidant production within HUVEC was assessed 
by measuring the oxidation of intracellular dihydror-
hodamine 123 (DHR 123; Molecular Probes, Inc.), an 
oxidant-sensitive fluorochrome, as described previ-
ously [30]. Briefly, the cells were treated with DHR 123 
(5mM) for 1h before being subjected to LPS stimula-
tion. After LPS stimulation the cells were washed with 
PBS, lysed, and DHR 123 oxidation was assessed 
spectrofluorometrically at excitation and emission 
wavelengths of 502 and 523 nm, respectively. 
Nitric oxide production 
NO production by HUVEC was assessed by 
measuring the fluorescence of 
4-amino-5-methylamino-2´, 7´-difluorofluorescein di-
acetate (DAF-FM diacetate), a specific NO probe (Mo-
lecular Probes, Inc.)[31]. Briefly, DAF-FM diacetate 
(10mM) in M199 was added to the HUVEC 1h before 
the LPS stimulation. After LPS stimulation, the 
HUVEC and supernatants were collected and ana-
lyzed spectrofluorometrically at excitation and emis-
sion wavelengths of 495 and 515 nm, respectively. Int. J. Biol. Sci. 2008, 4 
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Cell ELISA  
For assessment of ICAM-1 surface expression 
level, an ELISA was performed [32] on HUVEC grown 
in 96-well cell culture plates (Corning). HUVEC were 
fixed in 4% paraformaldehyde at 4°C for 30min. The 
cells were then washed two times with cold PBS and 
were incubated with the mouse primary antibody 
against human ICAM-1 at a concentration of 10µg/ml 
for 1h at room temperature. After this treatment, im-
munocytochemical staining of HUVEC monolayers 
was performed using an avidin-biotin-conjugated 
peroxidase mouse IgG staining kit, and MAb binding 
was subsequently quantified with a microplate reader 
(model 3550-UV; Bio- Rad) at 450-nm wavelength. 
SDS-polyacrylamide gel electrophoresis and Western 
blotting 
SDS-polyacrylamide gel electrophoresis and 
Western blotting were performed as described previ-
ously [33]. Samples (3μg of protein) were subjected to 
electrophoresis on 7% (for iNOS) or 12% (for HO-1) 
SDS-polyacrylamide gels, with the use of the discon-
tinuous system and transferred onto nitrocellulose 
membranes. The membranes were probed with 
anti-iNOS polyclonal antibody (1:2000), and anti-HO-1 
polyclonal antibody (1:2000). Anti-mouse IgG conju-
gated to horseradish peroxidase (1:2500) was used as a 
secondary antibody. The bands were visualized by the 
use of ECL reagent and Hyperfilm ECL (Amersham, 
Arlington Heights, IL) as described by the manufac-
turer. Films were scanned using a flatbed scanner and 
the bands were quantified using Basic Quantifier 
software (Bio Image, Ann Arbor, MI), an image analy-
sis program, on a Macintosh computer.   
HUVEC nuclear protein extraction. 
Nuclear protein was extracted from HUVEC as 
previously described [34,35]. Cells were grown to con-
fluence in Petri-dish, scraped, washed with cold PBS, 
and incubated in 150µl of buffer E(+) (0.3% Nonidet 
P-40, 10mM Tris (pH 8.0), 60mM NaCl, 1mM EDTA, 
0.5mM dithiothreitol (DTT), 1µg/ml aprotinin, 
1µg/ml leupeptin, and 1mM phenylmethylsulfonyl 
fluoride ) for 5 min on ice. Samples were centrifuged 
at 4°C for 5min at 500g. The supernatant was then re-
moved, and the pellets (nuclei) were resuspended in 
150µl of buffer E (10mM Tris (pH 8.0), 60mM NaCl, 
1mM EDTA, and 0.5mM DTT) and centrifuged at 500 
g for 5 min at 4°C. The nuclei were then extracted in 
30–50µl of buffer E(c)(20mM HEPES, 0.75mM sper-
midine, 0.15mM spermine, 0.2mM EDTA, 2mM 
EGTA, 2mM DTT, 20% glycerol, and 1mM PMSF (4°C) 
in the presence of 0.4MnaCl) and were incubated on 
ice for 20min. Finally, the samples were centrifuged 
for 10min at 500g (4°C), and the supernatants were 
collected and saved as the nuclear protein frac-
tion.Samples were stored at -80°C. 
Electrophoretic mobility shift assay(EMSA) 
The double-stranded oligonucleotide containing 
consensus (58-AGGGACTTCCGCTGGGGACTTTCC 
-38) binding sites for NF-κB (synthesized on site; 
Beckman-Oligo 1000M DNA synthesizer) were end 
labeled with [γ-32P] ATP (Amersham) by using 
T4-polynucleotide kinase (MBI Fermentas, Flambor-
ough, ON), as described previously [35]. One pico-
mole of the labeled oligonucleotide was incubated 
with 5µg of nuclear extract protein in the presence or 
absence of 50X excess of cold oligonucleotide. Samples 
were incubated for 30 min at room temperature and 
then run through a 4% nondenaturing polyacrylamide 
gel at 280V for 45-60 min. The gel was dried and then 
exposed to X-ray film (Kodak) in cassettes for 2-4 h at 
-80°C with intensifying screens. 
PMN adhesion assays.  
Human neutrophilic PMN were isolated from the 
venous blood of healthy adults using standard dex-
tran sedimentation and gradient separation on Histo-
paque-1077. This procedure yields a PMN population 
that is 95–98% viable (trypan blue exclusion) and 98% 
pure (acetic acid-crystal violet staining). 
For the static adhesion assay, isolated neutrophils 
were suspended in PBS buffer and radiolabeled by 
incubating the cells at 5 × 107 cells/ml with 50µCi 
Na51CrO4/ml PMN suspension at 37°C for 60min. The 
cells were then washed with cold PBS to remove un-
incorporated radioactivity. Radiolabeled PMN (5 × 
105/well) were added to HUVEC monolayers grown 
in 48-well plates (Costar), and 30min later the per-
centage of added PMN that remained adherent after a 
wash procedure was quantitated as follows: %PMN 
adherence = lysate (cpm)/[supernatant (cpm) + wash 
(cpm) + lysate (cpm)], where cpm is counts per min-
ute.  
Statistical Analysis  
All of the values are presented as means ± SD. 
Statistical analysis was performed with the use of 
ANOVA and Student's t-test for the comparisons. A 
value of P<0.05 was considered to be statistically sig-
nificant.  
Results 
Effects of CORM-2 pretreatment on induction of in-
tracellular oxidative stress (ROS) and NO production 
in LPS-stimulated HUVEC 
As shown in Fig. 1, LPS stimulation resulted in a 
significant increase in HUVEC oxidant production. Int. J. Biol. Sci. 2008, 4 
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Pretreatment of HUVEC with CORM-2 for 2h signifi-
cantly reduced oxidative stress (A) and NO produc-
tion (B) in response to LPS stimulation.   
 
 
Fig.1. Effects of CORM-2 pretreatment on induction of intra-
cellular oxidative stress (ROS) and NO production in 
LPS-stimulated HUVEC. Confluent HUVEC monolayers 
(48-well cell culture dishes) were pretreated with CORM-2 (50 
and 100μM) for 2h. Subsequently, HUVEC were washed and 
loaded with DHR123 or DAF-FM for additional 1h. Then, 
HUVEC were stimulated with LPS (10μg/ml) for 4hrs and 
oxidative stress (DHR123 oxidation) and NO production 
(DAF-FM nitration) were assessed. In some experiments, naïve 
(not-pretreated) HUVEC were stimulated with LPS in the 
presence of CORM-2 (50 and 100μM). Note that pretreatment 
of HUVEC with CORM-2 reduced oxidative stress (A) and NO 
production (B) in response to LPS stimulation. All values are 
expressed as mean ± SD (n = 4). ﹟p <0.05 as compared to LPS; 
*p <0.05 as compared to co-incubation with 50 μM CORM-2; * 
*p <0.05 as compared to co-incubation with 100 μM CORM-2. 
Effect of CORM-2 pretreatment on iNOS and HO-1 
expression in LPS-stimulated HUVEC (Western blot-
ting) 
At 4h after LPS stimulation, the expression of 
iNOS (Fig.2 A) and HO-1 (Fig.2 B) in HUVEC signifi-
cantly increased compared to the control. Both pre-
treatment and coincubation of CORM-2 in 
LPS-stimulated HUVECs significantly downregulated 
the expression of iNOS. However, CO preconditioning 
was more effective to downregulate the expression of 
iNOS compare to coincubation group. Interestingly, 
not only pretreatment, but also coincubation of 
CORM-2 in LPS-stimulated HUVECs significantly 
upregulated the expression of HO-1. 
 
 
Fig.2  Effects of CORM-2 pretreatment on iNOS and HO-1 
expression in LPS-stimulated HUVEC. The experimental con-
ditions were the same as described in Fig.1. iNOS and HO-1 
expression were determined by Western blot. Note that pre-
treatment of HUVEC with CORM-2 resulted in more effective 
inhibition of iNOS protein expression in LPS stimulated 
HUVEC compare to coincubation group,﹟p <0.05 as compared 
to LPS; *p <0.05 as compared to co-incubation with 50 μM 
CORM-2; * *p <0.05 as compared to co-incubation with 100 
μM CORM-2 (A). Both pretreatment and coincubation of 
CORM-2 significantly upregulated expression of HO-1 in 
LPS-stimulated HUVECs. Shown is a representative image 
from three experiments. *p <0.05 as compared to control, # p 
<0.05 as compared to LPS (B). Int. J. Biol. Sci. 2008, 4 
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Effect of CORM-2 pretreatment on ICAM-1 expression 
in LPS-stimulated HUVEC (cell ELISA) 
At 4h after LPS stimulation, the expression of 
ICAM-1 in HUVEC significantly increased compared 
to the control, while this increase was effectively in-
hibited after pretreatment or coincubation of CORM-2 
in HUVEC with no significant different.   
 
 
 
 
 
 
Fig.3 Effects of CORM-2 pretreatment on ICAM-1 surface 
expression in LPS-stimulated HUVEC. The experimental con-
ditions were the same as described in Fig.2. HUVEC 
pro-adhesive phenotype was assessed by measuring cell surface 
levels (cell ELISA) of ICAM-1 protein. Note that LPS-induced 
up-regulation of ICAM-1 surface levels was significantly re-
duced in CORM-2-pretreated or coincubated HUVEC. n=4; * 
P<0.05 compared to LPS. *﹟  P>0.05 compared to those 
co-incubated with 50 or 100 μM of CORM-2. 
Effect of CORM-2 pretreatment on activities of NF-κB 
in LPS-stimulated HUVEC  
Binding activities of nuclear protein to the radio-
labeled consensus binding sequences of NF-κB was 
assessed by EMSA. At 4h after LPS stimulation, the 
NF-κB activation in HUVEC was markedly increased 
and this activity was inhibited by pretreatment of 
CORM-2 with a concentration-dependent manner 
(Fig. 4). 
 
 
Fig.4 Effects of CORM-2 pretreatment on NF-kB activation in 
LPS-stimulated HUVEC. HUVEC were grown in 60 mm Petri 
dishes until confluence and pretreated with CORM-2 (50 and 
100μM) for 2 h. The control HUVECs were treated with the 
vehicle only. Subsequently, HUVEC were washed and stimu-
lated with LPS (10 µg/ml) for 4 hrs in the presence (coincuba-
tion) or absence of CORM-2 (50-100µM). NF-κB activation 
was assessed by EMSA. Note that LPS-induced activation of 
NF-κB was effectively prevented in CORM-2-pretreated 
HUVEC. Shown is a representative image from four experi-
ments. ﹟p <0.05 as compared to LPS; *p <0.05 as compared to 
co-incubation with 50 μM CORM-2; * *p <0.05 as compared to 
co-incubation with 100 μM CORM-2. Int. J. Biol. Sci. 2008, 4 
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Effect of CORM-2 pretreatment on PMN adhesion to 
LPS-stimulated HUVEC 
As shown in Fig.5, adhesion of PMN to HUVEC 
is low in control. After monolayer of endothelial cells 
were stimulated by LPS for 4h, adhesion of PMN to 
HUVEC significantly increased (P<0.01 compared to 
control). However, both pretreatment and coincuba-
tion with CORM-2 (50 and 100μM) markedly de-
creased leukocyte–endothelial cells adhesion (P<0.05 
compared to LPS group).   
 
Fig.5 Effects of CORM-2 pretreatment on PMN adhesion to 
LPS-stimulated HUVEC. HUVEC were grown to confluence in 
48-well cell culture dishes and pretreated with CORM-2 
(50-100µM) for 2 hr. Then HUVEC were washed and stimu-
lated with LPS (10 µg/ml) for additional 4 hrs in the presence 
(coincubation) or absence of CORM-2. Subsequently, HUVEC 
were washed and co-incubated with 51Cr-PMN (1×10
5) for 30 
min. Per cent of PMN adhesion to HUVEC was calculated based 
on the amount of radioactivity remaining in HUVEC monolay-
ers following two subsequent washes. Note that PMN adhesion 
to LPS-stimulated HUVEC was significantly reduced in 
CORM-2-pretreated or coincubated HUVEC. All values are 
expressed as mean ± SE (n = 3). * P<0.01 compared to LPS. *
﹟ P>0.05 compared to those coincubated with 50 or 100 μM of 
CORM-2. 
Discussion 
The present study investigated the effects of 
preconditioning of CORM-2 on decrease of inflam-
matory response and oxidative stress in 
LPS-stimulated HUVECs and possible molecular 
mechanisms. 
LPS from the bacteria can activate endothelial 
cells and stimulate their expression of adhesion mole-
cules, elicit the responsiveness of ECs through its abil-
ity to affect leukocyte adherence to activate vascular 
endothelium and the subsequent transendothelial mi-
gration. Many experimental studies have highlighted 
the specific and independent role of exogenous CO in 
the modulation of inflammation [36,37]. It is well 
known that heme oxygenase (HO) is a rate-limiting 
enzyme that is responsible for the catabolism of heme 
into bilirubin, free iron, and carbon monoxide (CO). 
Three HO isoforms have been identified; HO-2 and 
HO-3 isoforms are believed to be constitutive and 
physiologically expressed, whereas HO-1 isoform is a 
stress-responsive protein that is induced by various 
s t i m u l i .  T h e  a d a p t i v e  r e s p o n s e  o f  H O - 1  t o  v a r i o u s  
stimuli suggests that HO-1 may play an important role 
in protecting against inflammatory response and oxi-
dative injury [38].   Works from other laboratories 
have shown that the up-regulation of endogenous 
HO-1 ameliorates inflammatory responses and/or 
tissue damage [39]. As a new metal carbonyl-based 
compounds, CO-releasing moleculars (CO-RMs) have 
the ability to release CO in biological systems. The 
vasoactive, anti-hypertensive and anti-rejection effects 
of CO-RMs have been demonstrated to be due to the 
CO liberated by the compounds. CORM-2, a DMSO- 
soluble CORM, also has exhibited anti-inflammatory 
actions in an in vitro model of LPS-stimulated macro-
phages, and it was reported that the CO derived from 50 μM 
CORM-2 dissolved in DMSO (generating 50 ppm CO) was 
not cytotoxic by itself and did not enhance or reduce the 
cytotoxicity of LPS as was observed by Sawle et al [40]. 
Therefore, this led us to examine whether precondi-
tioning of CORM-2 could decrease oxidative stress, 
inhibit LPS-induced HUVEC activation. In this study, 
we found that HO-1 is significantly up-regulated in 
HUVECs by LPS stimulation. Interestingly, the ex-
pression of HO-1 in LPS-stimulated HUVECs with 
both preconditioning and coincuation of CORM-2 was 
more significantly increased compared to LPS group. 
This result indicated that not only LPS might signifi-
cantly induce the expression of HO-1, but also the in-
crease of HO-1 expression can be further enhanced by 
the administration of CORM-2. Through the 
by-product (CO, and / or biliverdin), the potent cyto-
protective and anti-inflammatory functions were ul-
timately led to exert. 
Based on current research findings,  oxidative 
stress is believed to be the major causative agent to 
damage the organs after injury. Nitrosative stress ini-
tiates an inflammatory cascade that includes acute 
phase protein synthesis, upregulation of inflammatory 
adhesion molecules, and proinflammatory cytokine 
release [41,42]. Thus, tissue or organ injury after 
trauma appears to be mediated both by reactive oxy-
gen species (ROS) and reactive nitrogen species (RNS) 
such as hydroxyl radical, superoxide anion, hydrogen 
peroxide, and peroxynitrite. It has been demonstrated 
that severe injury is associated with lipid peroxidation Int. J. Biol. Sci. 2008, 4 
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mediated by ROS and is believed to be an important 
cause of oxidative damage to cellular membranes and, 
eventually, cell death [43]. Also, nitric oxide (NO) 
plays a crucial role in cellular injury after trauma. It 
has been recognized that NO is produced by cNOS 
and/or iNOS in mice liver [44,45]. In this study, we 
found that LPS stimulation produces a significant 
upregulation of the inducible nitric oxide synthetase 
(iNOS), iNOS-mediated nitric oxide production then 
be upregulated. Our studies also demonstrated that 
administration of CORM-2 markedly down-regulated 
this increase both preconditioning and coincubation of 
CORM-2. However, preconditioning of CORM-2 is 
more effective to decrease the expression of iNOS and 
then decrease the production of ROS and NO with 
concentration-dependent manner. These data indi-
cated that preconditioning of exogenous CO was ca-
pable of effectively inhibiting inflammatory response 
and improving oxidative stress in activated HUVEC. 
Neutrophil (PMN)–endothelial cell (EC) interac-
tions are supposed to play a central role in the patho-
genesis of gut barrier failure following thermal injury 
and ischemia-reperfusion (I/R) [46]. Intercellular ad-
hesion molecule-1 (ICAM-1), mediating leukocyte ad-
hesion, presence correlates with infiltration of leuko-
cytes into inflammatory lesions [47,48]. Evidences 
showed that the direct cause of leukocytes sequestra-
tion is considered to be the more expression of adhe-
sion molecule (such as ICAM-1). ICAM-1 activates 
leukocytes and endothelial cells, which in turn prompt 
the release of various inflammatory mediators, result-
ing in systemic inflammatory response syndrome 
(SIRS), acute respiratory distress syndrome (ARDS) 
and multi-organ dysfunction syndrome (MODS) 
[49-51]. It was found in the present study that both 
preconditioning and co-incubation of CORM-2 could 
down-regulate the expression of ICAM-1 with no sig-
nificant difference. These results were in accordance 
with the PMN adhesion experiments (Fig.5) which 
showed that both preconditioning and co-incubation 
of CORM-2 could effectively decreased the PMNs ad-
hesion to LPS-stimulated HUVEC.   
There is no doubt that the nuclear factor κB 
(NF-κB) is a ubiquitous, rapidly acting transcription 
factor involved in immune and inflammatory reac-
tions, it exerts its immune and inflammatory response 
by regulating expression of cytokines, chemokines, 
cell adhesion molecules, and growth factors [52,53]. In 
this study, NF-κB activities in HUVEC were elevated 
by LPS stimulation while it was markedly inhibited by 
administration of CORM-2 with preconditioning or 
coincubation treatment. However, preconditioning of 
CORM-2 was more effective to inhibit NF-κB activities 
compared to CORM-2 coincubation group. These data 
showed that CORM-2 preconditioning plays a pivotal 
role in inhibition of NF-κΒ activity, subsequently de-
creased the expression of cellular adhesion molecules 
(ICAM-1) and LPS-induced pro-inflammatory media-
tors. Therefore, an effective therapeutic strategy that 
inhibit this transcription factor would be expected to 
improve organ functions in SIRS or sepsis. 
In summary, the present studies serve to clarify 
the role of preconditioning of CORM-2, one of the 
novel CO-releasing molecules, on the mechanisms of 
attenuation of inflammation and oxidative stress. 
Preconditioning of CORM-2 o n  L P S - s t i m u l a t e d  H U -
VECs upregulated the expression of HO-1 while 
downregulated the expression of iNOS, and subse-
quently decreased the production of ROS and NO. 
Also, preconditioning of CORM-2 effectively inhibited 
activation of NF-κΒ, which was accompanied by a de-
crease of the expression of ICAM-1. In parallel, PMN 
adhesion to HUVEC stimulated by LPS were mark-
edly decreased after CORM-2 admiistration both with 
preconditioning and coincubation treatment. Taken 
together these findings indicate that preconditioning 
of CORM-released CO is more effective to decrease 
the oxidative stress and inflammatory responses by 
interfering with NF-κΒ activation, protein expression 
of ICAM-1 and therefore suppressing endothelial cells 
pro-adhesive phenotype. 
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